Dr. Barbara Bryant

Dr. Barbara Bryant joined Carter BloodCare as CEO in 2024 after serving as Chief Medical Officer and Executive Vice President at Versiti, a national leader in blood banking and blood research.

Dr. Bryant received her undergraduate degree from the University of New Orleans and Louisiana State University Medical Center.  She was a blood bank medical technologist and specialist in blood banking for 17 years before attending medical school.  She earned her medical degree from the University of Texas Medical Branch (UTMB) where she completed a residency in Pathology.  She did her fellowship training in Transfusion Medicine/Blood Banking at the National Institutes of Health (NIH). 

Prior to serving as CMO and EVP at Versiti, Dr. Bryant was the Chief of the Department of Transfusion Medicine and the Center for Cellular Engineering at the NIH Clinical Center.  She has previously held faculty positions at UTMB where she was Professor and Vice Chair of the Department of Pathology, Medical Director of Transfusion Medicine and Apheresis, Director of Pathology Quality Management, and Director of the Academy of Master Clinicians. Dr. Bryant also served as the Medical Director of the Walking Blood Bank Program at the Center for Polar Medical Operations in Antarctica.

Dr, Bryant is an expert in transfusion medicine and her research is widely published.  She serves on several international, national and regional committees involving transfusion medicine practice, education, research, and patient blood management.